GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TCF12 | hg38_v1_chr15_+_56918763_56918832 | -0.37 | 1.3e-08 | Click! |
ASCL2 | hg38_v1_chr11_-_2270584_2270595 | 0.17 | 1.2e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr22_+_22899481 Show fit | 44.41 |
ENST00000390322.2
|
immunoglobulin lambda joining 2 |
|
chr21_-_44910630 Show fit | 32.41 |
ENST00000320216.10
ENST00000397852.5 |
integrin subunit beta 2 |
|
chr22_-_37486357 Show fit | 27.22 |
ENST00000356998.8
ENST00000416983.7 ENST00000424765.2 |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
|
chr16_+_23835946 Show fit | 26.83 |
ENST00000321728.12
ENST00000643927.1 |
protein kinase C beta |
|
chr2_+_90234809 Show fit | 26.66 |
ENST00000443397.5
|
immunoglobulin kappa variable 3D-7 |
|
chr14_-_106658251 Show fit | 25.55 |
ENST00000454421.2
|
immunoglobulin heavy variable 3-64 |
|
chr1_-_27635176 Show fit | 23.87 |
ENST00000374005.8
|
FGR proto-oncogene, Src family tyrosine kinase |
|
chr11_-_33869816 Show fit | 22.94 |
ENST00000395833.7
|
LIM domain only 2 |
|
chr22_+_22922594 Show fit | 22.87 |
ENST00000390331.3
|
immunoglobulin lambda constant 7 |
|
chr15_-_19965101 Show fit | 22.36 |
ENST00000338912.5
|
immunoglobulin heavy variable 1/OR15-9 (non-functional) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 246.8 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
2.3 | 217.3 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.3 | 197.7 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.9 | 60.7 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
0.9 | 50.5 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
4.6 | 37.1 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
12.1 | 36.2 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
2.1 | 31.4 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
4.4 | 30.6 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
5.9 | 29.4 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 218.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.1 | 68.1 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 45.8 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 40.6 | GO:0016604 | nuclear body(GO:0016604) |
2.1 | 39.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.4 | 35.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
6.5 | 32.4 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.5 | 29.6 | GO:0015030 | Cajal body(GO:0015030) |
0.4 | 28.0 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.7 | 26.3 | GO:0042629 | mast cell granule(GO:0042629) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 336.4 | GO:0003823 | antigen binding(GO:0003823) |
4.4 | 241.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 124.1 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.3 | 76.0 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 75.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.1 | 65.1 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.8 | 50.3 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
3.1 | 43.6 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.7 | 41.6 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
4.2 | 37.5 | GO:0043426 | MRF binding(GO:0043426) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 114.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
1.0 | 68.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.3 | 50.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 47.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 46.2 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 35.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.6 | 30.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.0 | 30.1 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.7 | 26.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.0 | 24.7 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 101.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.2 | 58.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.6 | 55.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.3 | 54.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.6 | 49.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.7 | 46.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.6 | 45.0 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 41.1 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
1.4 | 35.5 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.5 | 34.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |